227 related articles for article (PubMed ID: 19643208)
1. Malignancies in systemic lupus erythematosus.
Kiss E; Kovacs L; Szodoray P
Autoimmun Rev; 2010 Feb; 9(4):195-9. PubMed ID: 19643208
[TBL] [Abstract][Full Text] [Related]
2. Incidence of lymphoma associated with underlying lupus: lessons learned from observational studies.
Bichile T; Petri M
Curr Opin Rheumatol; 2014 Mar; 26(2):111-7. PubMed ID: 24419748
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL).
King JK; Costenbader KH
Clin Rheumatol; 2007 Sep; 26(9):1491-4. PubMed ID: 17297594
[TBL] [Abstract][Full Text] [Related]
4. Malignancy in systemic lupus erythematosus: what have we learned?
Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus and malignancies: a review article.
Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Rajan R; Boivin JF; Joseph L; Lachance S; Cournoyer D; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Steinsson K; Nived O; Sturfelt G; St Pierre Y; Clarke A
Ann Rheum Dis; 2005 Oct; 64(10):1507-9. PubMed ID: 16162903
[TBL] [Abstract][Full Text] [Related]
7. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
Chen YJ; Chang YT; Wang CB; Wu CY
Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Wang LH; Wang WM; Lin SH; Shieh CC
Rheumatology (Oxford); 2019 Jul; 58(7):1245-1249. PubMed ID: 30726952
[TBL] [Abstract][Full Text] [Related]
9. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
10. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
11. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
13. Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies.
Lanjewar S; McFarlane IM; Parker KN; Saad H; Haddadin M; Hirsch E; Benyaminov F; Kecelli M; Lazaro D; Bukhari Z; Gupta R; Haseeb MA
Medicine (Baltimore); 2021 May; 100(21):e25985. PubMed ID: 34032713
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus and infections.
Singh BK; Singh S
Reumatismo; 2020 Nov; 72(3):154-169. PubMed ID: 33213128
[TBL] [Abstract][Full Text] [Related]
15. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma in patients with systemic lupus erythematosus.
Papadaki HA; Xylouri I; Katrinakis G; Foudoulakis A; Kritikos HD; Stathopoulos EN; Boumpas DT; Eliopoulos GD
Leuk Lymphoma; 2003 Feb; 44(2):275-9. PubMed ID: 12688345
[TBL] [Abstract][Full Text] [Related]
18. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
[TBL] [Abstract][Full Text] [Related]
19. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
20. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]